Cargando…

Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review

RATIONALE: : Reinforcement of thinned or necrotizing sclera has been conducted using various materials, including allogeneic sclera, allogenic cornea, amniotic membrane, fascia lata, pericardium, periosteum, and perichondrium. Among them, good outcomes have traditionally been obtained using preserve...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Young-ho, Yoon, Chang Ho, Kim, Mee Kum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294895/
https://www.ncbi.nlm.nih.gov/pubmed/34398015
http://dx.doi.org/10.1097/MD.0000000000026607
_version_ 1783725324382502912
author Jung, Young-ho
Yoon, Chang Ho
Kim, Mee Kum
author_facet Jung, Young-ho
Yoon, Chang Ho
Kim, Mee Kum
author_sort Jung, Young-ho
collection PubMed
description RATIONALE: : Reinforcement of thinned or necrotizing sclera has been conducted using various materials, including allogeneic sclera, allogenic cornea, amniotic membrane, fascia lata, pericardium, periosteum, and perichondrium. Among them, good outcomes have traditionally been obtained using preserved scleral grafts. However, scleral patch grafts have complications such as graft retraction, thinning, dehiscence, and necrosis. Furthermore, to promote epithelial healing, scleral patch grafting must be accompanied by procedures such as amniotic membrane transplantation (AMT) or grafting using conjunctival flaps or autografts. Recently, acellular preserved human corneas have been used in various ophthalmic surgeries, with emerging evidence supporting its use for treating scleral defects as an option that does not require AMT or conjunctival autografting. We investigated whether corneal patch grafting would show wound healing and tectonic success rate outcomes comparable to those of existing techniques. PATIENT PRESENTATION: : Three patients presented with intractable ocular pain. Slit-lamp examination showed marked scleral thinning at the nasal side. DIAGNOSIS: : Scleral thinning progressed with conservative treatment; microbial staining and culturing were performed. Infectious or non-infectious scleritis was diagnosed according to slit-lamp examination and microbial culture results. INTERVENTIONS: : A preserved corneal lamellar patch was grafted at the scleral thinning area. OUTCOMES: All patients achieved tectonic success with reduction of inflammation following corneal patch grafting. Two patients achieved complete re-epithelialization within 7 days, while 25 days were required for the third patient. No patients experienced graft thinning, rejection, or infection. LESSONS: : Our report suggests the feasibility of using acellular preserved human cornea patch grafts to reinforce inflammatory scleral defects and obtain successful outcomes in terms of wound healing. This technique shows a comparable tectonic success rate and superior effect on scleral defect healing without the need for adjunctive AMT or conjunctival autografting.
format Online
Article
Text
id pubmed-8294895
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82948952021-07-24 Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review Jung, Young-ho Yoon, Chang Ho Kim, Mee Kum Medicine (Baltimore) 5800 RATIONALE: : Reinforcement of thinned or necrotizing sclera has been conducted using various materials, including allogeneic sclera, allogenic cornea, amniotic membrane, fascia lata, pericardium, periosteum, and perichondrium. Among them, good outcomes have traditionally been obtained using preserved scleral grafts. However, scleral patch grafts have complications such as graft retraction, thinning, dehiscence, and necrosis. Furthermore, to promote epithelial healing, scleral patch grafting must be accompanied by procedures such as amniotic membrane transplantation (AMT) or grafting using conjunctival flaps or autografts. Recently, acellular preserved human corneas have been used in various ophthalmic surgeries, with emerging evidence supporting its use for treating scleral defects as an option that does not require AMT or conjunctival autografting. We investigated whether corneal patch grafting would show wound healing and tectonic success rate outcomes comparable to those of existing techniques. PATIENT PRESENTATION: : Three patients presented with intractable ocular pain. Slit-lamp examination showed marked scleral thinning at the nasal side. DIAGNOSIS: : Scleral thinning progressed with conservative treatment; microbial staining and culturing were performed. Infectious or non-infectious scleritis was diagnosed according to slit-lamp examination and microbial culture results. INTERVENTIONS: : A preserved corneal lamellar patch was grafted at the scleral thinning area. OUTCOMES: All patients achieved tectonic success with reduction of inflammation following corneal patch grafting. Two patients achieved complete re-epithelialization within 7 days, while 25 days were required for the third patient. No patients experienced graft thinning, rejection, or infection. LESSONS: : Our report suggests the feasibility of using acellular preserved human cornea patch grafts to reinforce inflammatory scleral defects and obtain successful outcomes in terms of wound healing. This technique shows a comparable tectonic success rate and superior effect on scleral defect healing without the need for adjunctive AMT or conjunctival autografting. Lippincott Williams & Wilkins 2021-07-23 /pmc/articles/PMC8294895/ /pubmed/34398015 http://dx.doi.org/10.1097/MD.0000000000026607 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5800
Jung, Young-ho
Yoon, Chang Ho
Kim, Mee Kum
Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title_full Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title_fullStr Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title_full_unstemmed Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title_short Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review
title_sort preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: three case reports and literature review
topic 5800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294895/
https://www.ncbi.nlm.nih.gov/pubmed/34398015
http://dx.doi.org/10.1097/MD.0000000000026607
work_keys_str_mv AT jungyoungho preservedcorneallamellartransplantationforinfectiousandnoninfectiousscleraldefectsthreecasereportsandliteraturereview
AT yoonchangho preservedcorneallamellartransplantationforinfectiousandnoninfectiousscleraldefectsthreecasereportsandliteraturereview
AT kimmeekum preservedcorneallamellartransplantationforinfectiousandnoninfectiousscleraldefectsthreecasereportsandliteraturereview